Cannabinoids in attention-deficit/hyperactivity disorder: A randomised controlled trial (2017)

European Neuropsychopharmacology (Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P.)